ITOS ALL GOODBusiness Directories,Company Directories

Company Name: Corporate Name:	ITOS ALL GOOD
Company Title:
Company Description:
Keywords to Search:
Company Address:	141 St Lawrence,MERRICKVILLE,ON,Canada
ZIP Code: Postal Code:	K0G
Telephone Number:	6132692639
Fax Number:
Website:
Email:
USA SIC Code(Standard Industrial Classification Code):	100240
USA SIC Description:	FURNITURE
Number of Employees:
Sales Amount:
Credit History: Credit Report:	Institution
Contact Person:
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
JAMES JORDAN GALLERY STUDIO
JACKS GARAGE
JACKS GARAGE

Next company profile:
HUCKLEBUCKS
HOMEORGARDENCOM
HOLY TRINITY ANGLICAN CHURCH

Company News:

iTeos Therapeutics (ITOS) Stock Price Overview
Get the latest iTeos Therapeutics, Inc (ITOS) stock price with news, financials and other important investing information
iTeos Therapeutics Announces Its Intention to Wind Down
WATERTOWN, Mass and GOSSELIES, Belgium, May 28, 2025 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and
ITOS: ITeos Therapeutics Inc Latest Stock Price, Analysis, News and . . .
Get real-time ITeos Therapeutics Inc (ITOS) stock price, news, financials, community insights, and trading ideas Join 10 million+ investors and traders tracking markets in real-time on Stocktwits
iTeos Therapeutics (ITOS) Stock Price, News Analysis
Should You Buy or Sell iTeos Therapeutics Stock? Get The Latest ITOS Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat
iTeos Therapeutics, Inc. Enters Merger Agreement with . . . - Nasdaq
WATERTOWN, Mass and GOSSELIES, Belgium, July 21, 2025 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc (“iTeos”) (Nasdaq: ITOS) today announced that it has entered into a definitive merger
iTeos stock surges on plans to end operations (ITOS:NASDAQ)
iTeos Therapeutics (ITOS) stock surges 25% as the company announces plans to wind down operations, focusing on shareholder value Read more here
iTeos Therapeutics Stock Jumps Following Operational Closure . . . - MSN
Stock in iTeos Therapeutics Inc (NASDAQ:ITOS) climbed 21% following the company’s disclosure that its Board of Directors plans to discontinue business operations while concentrating on divesting
ITOS - iTeos Therapeutics, Inc. Stock - Stock Price, Institutional . . .
iTeos Therapeutics, Inc (NasdaqGM:ITOS) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size
iTeos Therapeutics To Wind Down Operations, Explores Asset Sale: Retail . . .
Shares of biopharmaceutical company iTeos Therapeutics, Inc (ITOS) traded 20% higher on Wednesday morning after the company announced its intent to wind down operations and explore asset sales
iTeos Therapeutics Announces Its Intention to Wind Down Operations
WATERTOWN, Mass and GOSSELIES, Belgium, May 28, 2025 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc (Nasdaq: ITOS), a clinical-stage biopharmaceutical company pioneering the discovery and development of a new generation of immuno-oncology therapeutics for patients, today announced the intention to wind down its operations as part of a